The Ratio of GrzB+ - FoxP3+ over CD3+ T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma.

导出 OA

翻译打印收藏纠错

作者： Giosuè,Scognamiglio ^[1] ; Mariaelena,Capone ^[2] ; Francesco,Sabbatino ^[3] ; Annabella,Di Mauro ^[1] ; Monica,Cantile ^[1] ; Margherita,Cerrone ^[1] ; Gabriele,Madonna ^[2] ; Antonio Maria,Grimaldi ^[2] ; Domenico,Mallardo ^[2] ; Marco,Palla ^[2] ; Sabrina,Sarno ^[4] ; Anna Maria,Anniciello ^[1] ; Maurizio,Di Bonito ^[1] ; Paolo Antonio,Ascierto ^[2] ; Gerardo,Botti ^[5]

作者单位： Pathology Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", 80131 Napoli, Italy. ^[1] Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", 80131 Napoli, Italy. ^[2] Oncology Unit, AOU San Giovanni di Dio e Ruggi d'Aragona, 84125 Salerno, Italy. ^[3] Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Napoli, Italy. ^[4] Scientific Direction, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", 80131 Napoli, Italy. ^[5]

关键词 immunoscore immunotherapy melanoma multiplex immunostaining tumor microenvironment

DOI 10.3390/cancers13102325

PMID 34066146

发布时间 2021-06-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交